Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.56 EUR | -1.11% | -2.73% | -21.24% |
04-02 | Shedir Pharma, into 2023 with rising revenues; profit down single digits | AN |
03-29 | Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 63M 67.36M 5.39B | Sales 2025 * | 67.7M 72.39M 5.8B | Capitalization | 40.45M 43.25M 3.46B |
---|---|---|---|---|---|
Net income 2024 * | 6M 6.42M 514M | Net income 2025 * | 7M 7.48M 599M | EV / Sales 2024 * | 0.42 x |
Net cash position 2024 * | 14.3M 15.29M 1.22B | Net cash position 2025 * | 23.1M 24.7M 1.98B | EV / Sales 2025 * | 0.26 x |
P/E ratio 2024 * |
6.03
x | P/E ratio 2025 * |
5.39
x | Employees | 79 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 12.01% |
1 day | -1.11% | ||
1 week | -2.73% | ||
Current month | -10.55% | ||
1 month | -6.81% | ||
3 months | -21.24% | ||
6 months | -21.59% | ||
Current year | -21.24% |
Managers | Title | Age | Since |
---|---|---|---|
Antonio Scala
CEO | Chief Executive Officer | 39 | 31/12/13 |
Giuseppe Somma
IRC | Investor Relations Contact | - | 30/06/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marco Mazzarese
BRD | Director/Board Member | 45 | 31/12/18 |
Lucio Fusaro
BRD | Director/Board Member | 68 | 31/12/21 |
Umberto di Maio
FOU | Founder | 51 | 12/10/14 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 3.56 | -1.11% | 7,250 |
25/04/24 | 3.6 | +2.27% | 7,250 |
24/04/24 | 3.52 | -3.30% | 19,500 |
23/04/24 | 3.64 | 0.00% | 0 |
22/04/24 | 3.64 | -0.55% | 2,000 |
Real-time Borsa Italiana, April 26, 2024 at 04:44 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.24% | 43.18M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- SHE Stock